Patent · US Active

Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors

US11919902B2 · kind B2 · utility

0Cited by

15References

13Claims

0Family size

Assignee

HiberCell, Inc. · US

Inventors

Johan Lindström · Huddinge, SE
Lars Boukharta Persson · Uppsala, SE
Madeleine Livendahl · Stuvsta-Snättringe, SE
Jenny Viklund · Kungshättan, SE
Tobias Ginman · Tullinge, SE
Rickard Forsblom · Tullinge, SE
Fredrik Rahm · Huddinge, SE
Edward A. Kesicki · Bothell, US
Kannan Karukurichi RAVI · Fords, US
Eugene Richard Hickey · Danbury, US
Markus Dahlgren · Stratford, US
Aleksey I. Gerasyuto · Flemington, US

Key dates

Filing date	Dec 21, 2018
Grant date	Mar 5, 2024
Priority date	—
Expiry date	Dec 21, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F5/025
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention relates to inhibitors of PI5P4K inhibitors useful in the treatment of cancers, neurodegenerative diseases, inflammatory disorders, and metabolic diseases, having the Formula:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.